Group One Trading’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,000
| Closed | -$2K | – | 5905 |
|
|
2018
Q3 | $2K | Sell |
2,000
-2,300
| -53% | -$3.85K | ﹤0.01% | 5054 |
|
|
2018
Q2 | $10K | Sell |
4,300
-1,100
| -20% | -$2.69K | ﹤0.01% | 4639 |
|
|
2018
Q1 | $13K | Buy |
5,400
+4,300
| +391% | +$10.8K | ﹤0.01% | 4250 |
|
|
2017
Q4 | $3K | Sell |
1,100
-63,200
| -98% | -$175K | ﹤0.01% | 4676 |
|
|
2017
Q3 | $203K | Buy |
64,300
+6,200
| +11% | +$19.9K | ﹤0.01% | 2748 |
|
|
2017
Q2 | $234K | Buy |
58,100
+42,600
| +275% | +$186K | ﹤0.01% | 2534 |
|
|
2017
Q1 | $57K | Buy |
+15,500
| New | +$48.6K | ﹤0.01% | 3325 |
|
|
2016
Q4 | – | Sell |
-410
| Closed | -$3K | – | 5230 |
|
|
2016
Q3 | $3K | Sell |
410
-270
| -40% | -$1.66K | ﹤0.01% | 4349 |
|
|
2016
Q2 | $3K | Buy |
+680
| New | +$4.44K | ﹤0.01% | 4411 |
|
|
2016
Q1 | – | Sell |
-1,610
| Closed | -$48K | – | 5353 |
|
|
2015
Q4 | $48K | Buy |
1,610
+1,110
| +222% | +$33.6K | ﹤0.01% | 3433 |
|
|
2015
Q3 | $16K | Sell |
500
-860
| -63% | -$41.1K | ﹤0.01% | 4145 |
|
|
2015
Q2 | $81K | Sell |
1,360
-1,800
| -57% | -$127K | ﹤0.01% | 3224 |
|
|
2015
Q1 | $338K | Buy |
3,160
+1,920
| +155% | +$183K | 0.01% | 1932 |
|
|
2014
Q4 | $116K | Buy |
1,240
+110
| +10% | +$10.5K | ﹤0.01% | 2733 |
|
|
2014
Q3 | $87K | Sell |
1,130
-3,730
| -77% | -$294K | ﹤0.01% | 3125 |
|
|
2014
Q2 | $436K | Buy |
4,860
+1,430
| +42% | +$87.6K | 0.01% | 1754 |
|
|
2014
Q1 | $184K | Buy |
+3,430
| New | +$113K | ﹤0.01% | 2515 |
|
Group One Trading's PTX Position: Q1 2019 in Review
Group One Trading sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 18,669 shares — an estimated $8K sold.
Group One Trading first reported a position in PTX in Q2 2013 and held it in 16 quarters. The position peaked at $285K in Q2 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Group One Trading reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Group One Trading sold 18,669 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $8K.
- Group One Trading first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 16 quarters.
- Group One Trading's Pernix Therapeutics Holdings, Inc. position peaked at $285K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.